Pharmacological exploitation of the alpha1-adrenoreceptor antagonist doxazosin to develop a novel class of antitumor agents that block intracellular protein kinase B/Akt activation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples